Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001493152-22-033848)

Filing Details

Accession Number:: 0001493152-22-033848
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2022-11-28 17:00:48
Reporting Period:: 2022-11-23

Accepted Time:: 2022-11-28 17:00:48
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1862150	Cingulate Inc.	CING	Pharmaceutical Preparations (2834)	863825535

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1883241	S. Craig Gilgallon	1901 W. 47Th Place Kansas City KS 66205	Evp, Gc And Secretary	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2022-11-23	3,575	$0.84	9,550	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	185,296	Indirect	By the Limerick Group, LLC

Footnotes

Reporting Person disclaims beneficial ownership of these securities except to the extent of their pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.